As a result, the translation of these biomarker candidates to real-life application in a clinical setting has lagged far behind. Quantitative, targeted proteomics approaches, however, are now ...
Meilahti Clinical Proteomics Core Facility is an optimised platform for clinical proteomics services. The broad expertise of our staff members both in clinical research and diseases provides the ...
A precision medicine workflow integrating proteomics and personalized xenograft models was developed and applied to an ...
Oncology Consulting's Amy Cripps discusses the implications of proteomics in cancer research and the developing potential it presents.Castle ...
Professor Jennifer Van Eyk joined Technology Networks for an exclusive interview at HUPO 2024 to discuss progress and bottlenecks in clinical proteomics Flow cytometry (FC) is a powerful tool for ...
In this interview, Asim Siddiqui, senior vice president and scientific fellow at Seer, explores the evolving role of unbiased ...
Why ALZpath, GeneDX, 10x Genomics, Protagonist Therapeutics, and Recursion are among the most innovative biotech companies of 2025.
the only serum biomarker currently available in routine clinical practice for the diagnosis of biliary and pancreatic cancers, is lacking in specificity and sensitivity. Bile proteomics is ...
Proteomics International Laboratories’ OxiDx has secured an Australian patent for a finger-prick test to measure muscle ...
24d
Medical Device Network on MSNProteomics announces Australian launch of predictive diabetic kidney testThe test will be accessible via healthcare professional referrals in Western Australia and the Northern Territory.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results